A matching‐adjusted indirect comparison of survival outcomes with pirtobrutinib ( BRUIN ) versus standard of care ( SCHOLAR ‐2) in relapsed/refractory mantle cell lymphoma previously treated with a covalent Bruton tyrosine kinase inhibitor

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Georg Heß, Toby A. Eyre, Min‐Hua Jen, Jiewen Zhang, Benjamin Goebel, Sarang Abhyankar, Martin Dreyling
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	British Journal of Haematology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet